JP Morgan Chase’s ContraFect Corporation CFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-62
| Closed | -$36 | – | 8107 |
|
|
2023
Q3 | $36 | Hold |
62
| – | – | ﹤0.01% | 7056 |
|
|
2023
Q2 | $92 | Hold |
62
| – | – | ﹤0.01% | 6704 |
|
|
2023
Q1 | $0 | Sell |
62
-1
| -2% | -$5 | ﹤0.01% | 7559 |
|
|
2022
Q4 | $0 | Hold |
63
| – | – | ﹤0.01% | 7400 |
|
|
2022
Q3 | $1K | Sell |
63
-31
| -33% | -$1.56K | ﹤0.01% | 6412 |
|
|
2022
Q2 | $23K | Hold |
94
| – | – | ﹤0.01% | 5866 |
|
|
2022
Q1 | $27K | Hold |
94
| – | – | ﹤0.01% | 6013 |
|
|
2021
Q4 | $20K | Buy |
94
+31
| +49% | +$8.51K | ﹤0.01% | 6229 |
|
|
2021
Q3 | $20K | Sell |
63
-689
| -92% | -$214K | ﹤0.01% | 6050 |
|
|
2021
Q2 | $265K | Buy |
752
+14
| +2% | +$4.58K | ﹤0.01% | 5090 |
|
|
2021
Q1 | $283K | Buy |
738
+422
| +134% | +$182K | ﹤0.01% | 5003 |
|
|
2020
Q4 | $128K | Buy |
316
+171
| +118% | +$74K | ﹤0.01% | 4946 |
|
|
2020
Q3 | $61K | Buy |
145
+21
| +17% | +$9.53K | ﹤0.01% | 4890 |
|
|
2020
Q2 | $63K | Buy |
124
+105
| +553% | +$51.6K | ﹤0.01% | 4749 |
|
|
2020
Q1 | $9K | Buy |
+19
| New | +$13K | ﹤0.01% | 5067 |
|
|
2018
Q4 | – | Sell |
-209
| Closed | -$346K | – | 6058 |
|
|
2018
Q3 | $346K | Buy |
209
+109
| +109% | +$180K | ﹤0.01% | 4460 |
|
|
2018
Q2 | $178K | Sell |
100
-3
| -3% | -$4.42K | ﹤0.01% | 4609 |
|
|
2018
Q1 | $131K | Buy |
+103
| New | +$127K | ﹤0.01% | 4511 |
|
Other funds holding CFRX
JP Morgan Chase's CFRX Position: Q4 2023 in Review
JP Morgan Chase sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 62 shares — an estimated $36 sold.
JP Morgan Chase first reported a position in CFRX in Q1 2018 and held it in 18 quarters. The position peaked at $346K in Q3 2018. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.
- JP Morgan Chase reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
- JP Morgan Chase sold 62 ContraFect Corporation shares in Q4 2023, an estimated $36.
- JP Morgan Chase first reported a position in ContraFect Corporation in Q1 2018 and held it in 18 quarters.
- JP Morgan Chase's ContraFect Corporation position peaked at $346K in Q3 2018.
- 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.